# Reirradiation Dose Escalation in Thoracic Cancers

> **NCT06558175** · PHASE1 · NOT_YET_RECRUITING · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 48 (estimated)

## Conditions studied

- Thoracic Cancer
- Lung Cancer
- Esophageal Cancer

## Interventions

- **RADIATION:** stereotactic body radiation therapy (SBRT)

## Key facts

- **NCT ID:** NCT06558175
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-30
- **Primary completion:** 2026-10-30
- **Final completion:** 2027-01-29
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2024-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06558175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06558175, "Reirradiation Dose Escalation in Thoracic Cancers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06558175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*